The decision was taken after the study did not meet the primary and key secondary endpoints ... in participants with LRRK2-associated Parkinson’s disease (LRRK2-PD). The phase IIa study will ...

During this time, the Parkinson’s community comes together to raise awareness about the challenges of living with this ...

Could it be possible to diagnose Parkinson's disease with the help of a simple retinal exam? The idea should be seriously ...

AI Tool to Better Assess Parkinson's Disease, Other Movement Disorders ... for specialty care after being referred by their primary care physician or another physician, according to a new study.

Among patients with Parkinson disease with obstructive sleep apnea, PAP therapy improved cognitive function over 6 months.

An experimental therapy for Parkinson's disease being developed by Roche and ... stage Parkinson's compared to placebo, missing its primary endpoint. The disappointing result comes after ...

There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor symptoms associated with Parkinson’s disease.

This initiative, which involves dog walking events across various Belgian cities, aimed to support individuals affected by Parkinson’s disease ... activity remains the primary natural ...